Back to Search Start Over

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)

Authors :
Stephanie A. Smith-Warner
Mark P. Purdue
William J. Blot
Eric J. Jacobs
Neil E. Caporaso
Meir J. Stampfer
Woon-Puay Koh
Qiuyin Cai
Tricia L Larose
Gianluca Severi
Mikael Johansson
Florence Guida
Jonas Manjer
Anne Zeleniuch-Jacquotte
Graham G. Giles
Yu-Tang Gao
Demetrius Albanes
Allison M. Hodge
Neal D. Freedman
I-Min Lee
Christopher A. Haiman
Øivind Midttun
Mary Pettinger
Ross L. Prentice
Kala Visvanathan
Loic Le Marchand
Cynthia A. Thomson
Jie Wu
Howard D. Sesso
Stephanie J. Weinstein
Kristian Kveem
Alan A. Arslan
J. Michael Gaziano
Wei Zheng
Arnulf Langhammer
Yong-Bing Xiang
Mattias Johansson
Lynne R. Wilkens
Jian-Min Yuan
Paul Brennan
Victoria L. Stevens
Xuehong Zhang
Honglan Li
Per Magne Ueland
Qing Lan
Julie E. Buring
Edward Giovannucci
Kjell Grankvist
Renwei Wang
Hans Brunnström
Judith A. Hoffman Bolton
Anouar Fanidi
Xiao-Ou Shu
Source :
International Journal of Epidemiology
Publication Year :
2018
Publisher :
Oxford University Press, 2018.

Abstract

Background Self-reported smoking is the principal measure used to assess lung cancer risk in epidemiological studies. We evaluated if circulating cotinine—a nicotine metabolite and biomarker of recent tobacco exposure—provides additional information on lung cancer risk. Methods The study was conducted in the Lung Cancer Cohort Consortium (LC3) involving 20 prospective cohort studies. Pre-diagnostic serum cotinine concentrations were measured in one laboratory on 5364 lung cancer cases and 5364 individually matched controls. We used conditional logistic regression to evaluate the association between circulating cotinine and lung cancer, and assessed if cotinine provided additional risk-discriminative information compared with self-reported smoking (smoking status, smoking intensity, smoking duration), using receiver-operating characteristic (ROC) curve analysis. Results We observed a strong positive association between cotinine and lung cancer risk for current smokers [odds ratio (OR ) per 500 nmol/L increase in cotinine (OR500): 1.39, 95% confidence interval (CI): 1.32–1.47]. Cotinine concentrations consistent with active smoking (≥115 nmol/L) were common in former smokers (cases: 14.6%; controls: 9.2%) and rare in never smokers (cases: 2.7%; controls: 0.8%). Former and never smokers with cotinine concentrations indicative of active smoking (≥115 nmol/L) also showed increased lung cancer risk. For current smokers, the risk-discriminative performance of cotinine combined with self-reported smoking (AUCintegrated: 0.69, 95% CI: 0.68–0.71) yielded a small improvement over self-reported smoking alone (AUCsmoke: 0.66, 95% CI: 0.64–0.68) (P = 1.5x10–9). Conclusions Circulating cotinine concentrations are consistently associated with lung cancer risk for current smokers and provide additional risk-discriminative information compared with self-report smoking alone. © The Author(s) 2018; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association

Details

Language :
English
Database :
OpenAIRE
Journal :
International Journal of Epidemiology
Accession number :
edsair.doi.dedup.....405e2a4508c5b76f0db37244ba6ce63f